Deerfield, IL, United States of America

Derek Wiebenson

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Baxter Healthcare Sa, Baxter International Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Derek Wiebenson. Retrieved from https://idiyas.com/inventor/derek-wiebenson-3aithx2m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Derek Wiebenson - Innovative Inventor from Deerfield, IL

Introduction: Derek Wiebenson is a talented inventor based in Deerfield, Illinois, known for his groundbreaking contributions to various industries.

Latest Patents: Derek Wiebenson holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Derek Wiebenson has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating solutions through his inventions.

Collaborations: Throughout his career, Derek Wiebenson has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Derek Wiebenson's passion for innovation and his relentless drive to push the boundaries of what is possible make him a standout figure in the world of inventors, with a promising future ahead in shaping the landscape of various industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…